動物用抗菌薬感受性試験市場：製品タイプ、動物タイプ、エンドユーザー別-2025-2030年の世界予測

動物用抗菌薬感受性試験市場は、2023年に1億459万米ドルと評価され、2024年には1億1,338万米ドルに達すると予測され、CAGR 8.50%で成長し、2030年には1億8,519万米ドルになると予測されています。

動物用抗菌薬感受性試験（VAST）は、動物の感染症を診断・管理し、抗菌薬の正しい使用を促進し、抗菌薬耐性（AMR）の蔓延を緩和するために不可欠です。VASTの必要性は、動物の健康と福祉を確保し、公衆衛生を守り、AMRの懸念が高まる中で抗菌薬の有効性を管理する差し迫った必要性から生じています。VASTは、主に家畜、コンパニオンアニマル、水産養殖を対象として、臨床現場、農業現場、研究機関で応用されています。市場成長への洞察は、動物衛生意識の高まり、診断技術の革新、責任ある抗菌薬使用を提唱する規制政策によってもたらされます。分子診断技術の登場は、感受性試験のスピードと精度を高め、市場拡大に大きく寄与しています。さらに、獣医療サービスの民営化の進展と世界のペット飼育率の上昇が需要を後押ししています。しかし、特に小規模な事業者にとっては、検査機器や検査工程にかかるコストが高いことや、検査手順が世界的に標準化されていないことなどが、顕著な制約となっています。さらに、AMRパターンの複雑さや、地域ごとの最新の感受性データが限られていることも課題となっています。このような課題にもかかわらず、診断効率と抗菌薬スチュワードシップを向上させる、迅速で費用対効果の高いポイントオブケア検査ソリューションと統合データ管理システムの開発には、有望な機会があります。このような展望をつかむために、利害関係者は自動化・小型化された検査プラットフォームの研究開発に投資し、感受性検査手法の調和を図るための世界の取り組みに協力すべきです。革新的な分野としては、診断におけるナノテクノロジーの進展や、抗菌薬使用パターンの予測分析における人工知能の活用などが挙げられます。VAST市場は、技術の進歩と規制の影響を特徴とするダイナミックな市場です。進化する業界標準と技術進歩に戦略的に対応する利害関係者は、競争力を確保し、世界の抗菌剤管理の取り組みに有意義に貢献することができます。

市場力学：急速に進化する動物用抗菌薬感受性試験市場の主要市場インサイトを公開

動物用抗菌薬感受性試験市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • コンパニオンアニマルおよび家畜の飼育数の増加
  • 家畜の死亡率と疾病率の上昇
  • 抗菌薬耐性に対処する国家戦略を策定する政府の取り組み
• 市場抑制要因
  • 効率性の欠如と設備・材料費の高騰
• 市場機会
  • 動物用抗菌薬感受性試験における技術の進歩
  • ベンダーによる戦略的提携と投資の増加
• 市場の課題
  • 薬物動態プロファイルの大きな個人差

ポーターの5つの力：動物用抗菌薬感受性試験市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用抗菌薬感受性試験市場における外部からの影響の把握

外部マクロ環境要因は、動物用抗菌薬感受性試験市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用抗菌薬感受性試験市場における競合情勢の把握

動物用抗菌薬感受性試験市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用抗菌薬感受性試験市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用抗菌薬感受性試験市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用抗菌薬感受性試験市場における成功への道筋を描く

動物用抗菌薬感受性試験市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ペットや家畜の飼育数の増加
    • 家畜の死亡率と疾病率の上昇
    • 抗菌薬耐性に対処するための国家戦略を策定する政府の取り組み
  • 抑制要因
    • 効率性の欠如と設備や資材のコスト高
  • 機会
    • 動物用抗菌薬感受性試験における技術の進歩
    • ベンダーによる戦略的提携と投資の増加
  • 課題
    • 薬物動態プロファイルにおける個人差が大きい
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用抗菌薬感受性試験市場：製品別

• アクセサリと消耗品
• 自動AST機器
• 文化メディア
• ディスクとプレート

第7章 動物用抗菌薬感受性試験市場動物の種類別

• コンパニオンアニマル
• 食用動物

第8章 動物用抗菌薬感受性試験市場：エンドユーザー別

• 獣医学参考研究所
• 獣医学調査機関および大学

第9章 南北アメリカの動物用抗菌薬感受性試験市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の動物用抗菌薬感受性試験市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの動物用抗菌薬感受性試験市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bioguard Corporation
• BioMerieux S.A.
• Bruker Corporation
• FASTinov S.A.
• Hardy Diagnostics
• Himedia Laboratories
• IDEXX Laboratories, Inc.
• LABORATORIOS CONDA, S.A.
• Liofilchem S.r.l.
• Mast Group Ltd.
• Neogen Corporation
• SSI Diagnostica A/S
• Synoptics Ltd
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY AUTOMATED AST INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY DISKS & PLATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY FOOD-PRODUCING ANIMALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY VETERINARY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. VETERINARY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Veterinary Antimicrobial Susceptibility Testing Market was valued at USD 104.59 million in 2023, expected to reach USD 113.38 million in 2024, and is projected to grow at a CAGR of 8.50%, to USD 185.19 million by 2030.

Veterinary Antimicrobial Susceptibility Testing (VAST) is integral to diagnosing and managing infectious diseases in animals, facilitating the correct use of antimicrobials, and mitigating the spread of antimicrobial resistance (AMR). The necessity of VAST arises from the pressing need to ensure animal health and welfare, safeguard public health, and manage antimicrobial efficacy amid escalating AMR concerns. It finds applications in clinical settings, agricultural practices, and research institutions, primarily focusing on livestock, companion animals, and aquaculture. Insights into market growth are driven by increasing animal health awareness, innovation in diagnostic technologies, and regulatory policies advocating for responsible antimicrobial use. The advent of molecular diagnostic technologies, enhancing the speed and precision of susceptibility testing, is a significant contributor to market expansion. Moreover, the growing privatization of veterinary services and the rise in pet ownership worldwide are bolstering demand. However, notable limitations include high costs of testing equipment and processes, especially for small-scale operators, and a lack of standardization in testing procedures globally. Additional challenges stem from the complexity of AMR patterns and the limited availability of updated regional susceptibility data. Despite these challenges, there are promising opportunities in developing rapid, cost-effective point-of-care testing solutions and integrated data management systems that enhance diagnostic efficiency and antimicrobial stewardship. To seize these prospects, stakeholders should invest in R&D for automated and miniaturized testing platforms and collaborate on global initiatives for harmonizing susceptibility testing methodologies. Innovation areas include advancing nanotechnology in diagnostics and leveraging artificial intelligence for predictive analytics in antimicrobial usage patterns. The VAST market is dynamic, characterized by technological advancements and regulatory influences. Stakeholders who strategically align their operations with evolving industry standards and technological progress can secure a competitive edge and contribute meaningfully to global antimicrobial management efforts.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Antimicrobial Susceptibility Testing Market

The Veterinary Antimicrobial Susceptibility Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Rising mortality and disease rates in farm animals
  • Government initiatives to develop national strategy to address antimicrobial resistance
• Market Restraints
  • Lack of efficiency and higher cost in terms of equipment and materials
• Market Opportunities
  • Technological advances in veterinary antimicrobial susceptibility testing
  • Increasing strategic alliances and investments by vendors
• Market Challenges
  • Large inter-individual differences in pharmacokinetic profiles

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Antimicrobial Susceptibility Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Antimicrobial Susceptibility Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Antimicrobial Susceptibility Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Antimicrobial Susceptibility Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Antimicrobial Susceptibility Testing Market

A detailed market share analysis in the Veterinary Antimicrobial Susceptibility Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Antimicrobial Susceptibility Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Antimicrobial Susceptibility Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Antimicrobial Susceptibility Testing Market

A strategic analysis of the Veterinary Antimicrobial Susceptibility Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bioguard Corporation, BioMerieux S.A., Bruker Corporation, FASTinov S.A., Hardy Diagnostics, Himedia Laboratories, IDEXX Laboratories, Inc., LABORATORIOS CONDA, S.A., Liofilchem S.r.l., Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synoptics Ltd, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Antimicrobial Susceptibility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories & Consumables, Automated Ast Instruments, Culture Media, and Disks & Plates.
• Based on Animal Type, market is studied across Companion Animals and Food-Producing Animals.
• Based on End-user, market is studied across Veterinary Reference Laboratories and Veterinary Research Institutes & Universities.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Rising mortality and disease rates in farm animals
    • 5.1.1.3. Government initiatives to develop national strategy to address antimicrobial resistance
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of efficiency and higher cost in terms of equipment and materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advances in veterinary antimicrobial susceptibility testing
    • 5.1.3.2. Increasing strategic alliances and investments by vendors
  • 5.1.4. Challenges
    • 5.1.4.1. Large inter-individual differences in pharmacokinetic profiles
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Antimicrobial Susceptibility Testing Market, by Product

• 6.1. Introduction
• 6.2. Accessories & Consumables
• 6.3. Automated Ast Instruments
• 6.4. Culture Media
• 6.5. Disks & Plates

7. Veterinary Antimicrobial Susceptibility Testing Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animals
• 7.3. Food-Producing Animals

8. Veterinary Antimicrobial Susceptibility Testing Market, by End-user

• 8.1. Introduction
• 8.2. Veterinary Reference Laboratories
• 8.3. Veterinary Research Institutes & Universities

9. Americas Veterinary Antimicrobial Susceptibility Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. Bio-Rad Laboratories, Inc.
• 3. Bioguard Corporation
• 4. BioMerieux S.A.
• 5. Bruker Corporation
• 6. FASTinov S.A.
• 7. Hardy Diagnostics
• 8. Himedia Laboratories
• 9. IDEXX Laboratories, Inc.
• 10. LABORATORIOS CONDA, S.A.
• 11. Liofilchem S.r.l.
• 12. Mast Group Ltd.
• 13. Neogen Corporation
• 14. SSI Diagnostica A/S
• 15. Synoptics Ltd
• 16. Thermo Fisher Scientific Inc.